Bill Text: NY A05953 | 2019-2020 | General Assembly | Introduced
Bill Title: Requires all opioid treatment programs to have buprenorphine available for prescription to addicts.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2020-01-08 - referred to alcoholism and drug abuse [A05953 Detail]
Download: New_York-2019-A05953-Introduced.html
STATE OF NEW YORK ________________________________________________________________________ 5953 2019-2020 Regular Sessions IN ASSEMBLY February 20, 2019 ___________ Introduced by M. of A. L. ROSENTHAL -- read once and referred to the Committee on Alcoholism and Drug Abuse AN ACT to amend the mental hygiene law, in relation to the availability of buprenorphine in opioid treatment programs The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. The mental hygiene law is amended by adding a new section 2 32.12 to read as follows: 3 § 32.12 Availability of buprenorphine. 4 Any provider of services or facility providing chemical dependence 5 services shall have buprenorphine available to be administered to 6 addicts. Such controlled substance shall be administered by a physician 7 or group of physicians pursuant to subdivision (b) of section 32.05 of 8 this article. 9 § 2. This act shall take effect on the one hundred twentieth day after 10 it shall have become a law. Effective immediately, the addition, amend- 11 ment and/or repeal of any rule or regulation necessary for the implemen- 12 tation of this act on its effective date are authorized to be made and 13 completed on or before such effective date. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD04835-01-9
